-
Study aim
-
Determine the effect of induced blood pressure reduction on cognitive function in people candidate for rhinoplasty surgery in Rafsanjan
-
Design
-
Clinical trial with a control group, parallel groups, double-blind, randomized, phase 2 on 50 patients.Random allocation software will be used for randomization.
-
Settings and conduct
-
Patients are randomly divided into two groups A and B. Induced hypotension will applied by Remifentanil, in group A but it is not applied in group B, and by tranxamic acid will be used to control bleeding. In this study, the researcher, person who responsible for following up the patients, the statistician were blind to the study.
-
Participants/Inclusion and exclusion criteria
-
Patients between the ages of 15 and 45, with the ability to read and write and "American society of anesthesiology" class,2, can enter this study. If the patients do not want to participate in the study, the history of blood coagulation disorder or the occurrence of anesthesia complication during surgery, such as airway spasm or desaturation, the subject will be excluded from the study.
-
Intervention groups
-
In the intervention group (group A), remifentanil was used in order to reduce blood pressure, to control bleeding at the operation site, and the dose of remifentanil was adjusted so that the mean arterial pressure was decrease more than 30% of the bloop pressure before anesthesia induction or mean blood pressure decreases to 50 to 65. In the control group (group B), induced blood pressure is not given so that the patient's blood pressure is maintained above 50 to 65 mm Hg or lower than 30% of the initial blood pressure.
-
Main outcome variables
-
The individual's cognitive performance is compared by "minimum mental status test", Beck questionnaire and Paced Auditory Serial Addition Test (PASAT) after surgery in two groups.